Prevalence, outcome and quality of care among children hospitalized with severe acute malnutrition in Kenyan hospitals: A multi-site observational study.

PloS One
Susan GachauClinical Information Network author group

Abstract

Severe acute malnutrition (SAM) remains a major cause of admission and inpatient mortality worldwide in children aged less than 5 years. In this study, we explored SAM prevalence and outcomes in children admitted in 13 Kenyan hospitals participating in a Clinical Information Network (CIN). We also describe their immediate in-patient management. We analyzed data for children aged 1-59 months collected retrospectively from medical records after discharge. Mean, median and ranges were used to summarize pooled and age-specific prevalence and mortality associated with SAM. Documentation of key signs and symptoms (S/S) and performance of indicators of quality of care for selected aspects of the WHO management steps were assessed. Logistic regression models were used to evaluate associations between documented S/S and mortality among SAM patients aged 6-59 months. Loess curves were used to explore performance change over time for indicators of selected SAM management steps. 5306/54140 (9.8%) children aged 1-59 months admitted with medical conditions in CIN hospitals between December 2013 and November 2016 had SAM. SAM prevalence identified by clinicians and case fatality varied widely across hospitals with median proportion (range) of...Continue Reading

References

Apr 21, 2006·The Cochrane Database of Systematic Reviews·G JamtvedtA D Oxman
May 4, 2006·Archives of Disease in Childhood·Nadina KaraolisClaire Schofield
Jul 22, 2006·BMC International Health and Human Rights·Sekela MwakyusaMike English
Apr 1, 2008·Journal of Pediatric Gastroenterology and Nutrition·Carlos BernalJorge Botero
Aug 23, 2008·Archives of Disease in Childhood·Grace IrimuMike English
Jan 25, 2012·Bulletin of the World Health Organization·Mike EnglishJim Todd
Feb 19, 2016·The American Journal of Clinical Nutrition·Andrew M PrenticeSophie E Moore
Apr 28, 2016·Archives of Disease in Childhood·Katherine Y H ChenNigel Curtis
Sep 23, 2016·Journal of Exercise Rehabilitation·Abey Bekele, Balamurugan Janakiraman
Oct 7, 2016·Bulletin of the World Health Organization·Kirkby D Tickell, Donna M Denno
Oct 21, 2016·Malaria Journal·Beatrice I AmbokoUNKNOWN Clinical Information Network authors
Dec 7, 2016·The American Journal of Tropical Medicine and Hygiene·Julius ThomasMike English
Aug 29, 2017·Health Research Policy and Systems·Krista M English, Babak Pourbohloul

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

Research Electronic Data Capture ( REDCap )

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.